News

The study represents the first part of Peregrine’s FDA approved product registration clinical trial for Cotara. The trial will enroll patients at four New Approaches to Brain Tumor

The declaration was made in a resolution adopted at the end of the Regional Committee for Africa’s fifty-fifth session in Maputo, Mozambique. The resolution urges Member States in

If approved for this new indication, the company says Femara will become the only breast cancer treatment approved in the US to significantly reduce the risk of recurrence

None of these gene variants have previously been associated with myocardial infarction (MI), and they could lead to the identification of new coronary heart disease (CHD) mechanisms. Celera

St Paul’s agreement includes the distribution of Ferrazone in Vietnam, Cambodia and Laos with a potential market of over 100 million people. Ferrazone is Akzo Nobel’s brand name

The phase II study results that showed a reduction in mortality in eritoran-treated patients versus placebo. The company plans to initiate a phase III clinical program after consulting

Awarded by the National Human Genome Research Institute (NHGRI), one of 27 institutes and centers at the National Institutes of Health (NIH), the NHGRI “Near-Term Development for Genome

Although research on humans is still a distant possibility, the scientists believe their discovery may hold promise in the treatment of a variety of illnesses linked to memory.

Researchers from Leiden University Medical Center in the Netherlands used magnetic resonance imaging (MRI) to examine the brains of elderly patients with and without dementia related to Alzheimer’s